"Moriggia Pelascini" Hospital
Gravedona, Como, 22015, Italy
NCT Number: NCT05143320
Recent studies suggest cognitive, emotional and behavioural impairments occur in patients after SARS-CoV-2 infection. Problems with memory, attention, information processing and executive functions are particularly prevalent in these patients, probably due to hypothesised sensitivity of the hippocampus to the virus. Cognitive impairment is also present in patients with no neurological, neuropsychological and neuropsychiatric history. Therefore, the aim of the present study is to describe neuropsychological and neuropsychiatric features in patients recovered from moderate to severe forms of Covid-19 some weeks after hospital dismission.
Looking for future studies?
Notify Me30 year–70 year
All sexes
Observational
Gravedona, Como, 22015, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: About 20 days after hospital dismission
Prevalence of neuropsychological and neuropsychiatric impairment in patients after hospitalization in patients with Sars-Cov2 infection.
Ospedale Generale Di Zona Moriggia-Pelascini
Other
Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: an Italian Sample.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07079670
COVID-19, Coronaviridae Infections
Phoenix, Arizona, United States
View Trial DetailsNCT07069309
COVID-19, Coronaviridae Infections
Walnut Creek, California, United States
View Trial DetailsNCT05997290
COVID-19, Coronaviridae Infections
Athens, Alabama, United States
View Trial DetailsNCT05168813
Blood-Borne Infections, COVID-19
Gaborone, Botswana
View Trial Details